Drug reformulation on the global stage
By leon-nanodrugs GmbH
Based on its cutting-edge microjet reactor (MJR) technology platform, leon-nanodrugs is on its way to becoming one of the leading companies in the reformulation arena for poorly soluble or non-soluble oral and parenteral drugs. Dr Wolfgang Beier, CSO and co-founder of leon, answers World Pharmaceutical Frontiers’ questions.